Celgene Markman ruling a positive, says RBC Capital

... marketing a generic version of the MDS Anemia treatment is being held in the U.S. District Court of New Jersey in Newark, New Jersey on May 15. Analyst sees Celgene triumphing in key patent hearing Celgene (CELG) is better positioned than its ...

http://ift.tt/1pgKgXC